This week I remind readers about last-minute financial moves they may need to make before the year ends. Read More

Pro-marijuana politicians in Congress haven’t given up on efforts to increase the marijuana industry’s access to mainstream banking. Read More

Favorable fundamental and technical factors support a bull case for the rest of 2023 and into next year. But prepare for bumps along the way. Read More

This week, we dive into the latest delay from the SEC, Tether's $500 million bet on BTC mining, and Solana's surge to prominence. Read More

Small-capitalization stocks have been surging lately, a sign of economic resilience. The trend is poised to accelerate in 2024. Read More

The stock market has gained no ground over the past five months, while we've booked several triple-digit winners. Read More

In a week marked by several positive developments, the financial landscape has been reshaped, propelling the S&P 500 to a three-month high. Read More

A major health insurance firm announced this week that it would cover psilocybin therapy. The mainstreaming of psychedelics continues apace. Read More

In the retail sector, investors are faced with a fragmented group of struggling companies, which means that attention to detail is key. Read More

When it comes to views of the economy, there’s a stark disconnect between public opinion and the truth. Here’s a look at the facts. Read More